Proton therapy-revolutionary advance or diminishing returns?

Nature Reviews Urology

Volumn 10, Issue 3, 2013, Pages 128-129

  Gray, Phillip J ^a   Efstathiou, Jason A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED RADIOTHERAPY; GASTROINTESTINAL TOXICITY; HEALTH CARE COST; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MEDICAL TECHNOLOGY; MEDICARE; PATIENT SAFETY; PRIORITY JOURNAL; PROSTATE CANCER; PROTON THERAPY; QUALITY OF LIFE; RADIATION INJURY; RADIATION SAFETY; UROGENITAL TRACT INJURY; COST; ECONOMICS; MALE; PROSTATE TUMOR;

COSTS AND COST ANALYSIS; HUMANS; MALE; PROSTATIC NEOPLASMS; PROTON THERAPY;

EID: 84875226760     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2013.16     Document Type: Article

References (10)

1. Zietman, A. L. et al. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: Long-term results from proton radiation oncology group/american college of radiology 95-09. J. Clin. Oncol. 28, 1106-1111 (2010).
2. Yu, J. B. et al. Proton versus intensity-modulated radiotherapy for prostate cancer: Patterns of care and early toxicity. J. Natl Cancer Inst. 105, 25-32 (2012).
3. McGee, L. et al. Outcomes in men with large prostates (≥60 cm(3)) treated with definitive proton therapy for prostate cancer. Acta Oncol. http://dx.doi.org/10.3109/0284186X.2012.744467.
4. Dearnaley, D. P. et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomised trial. Lancet 353, 267-272 (1999).
5. Gray, P. J. et al. Patient-reported outcomes following 3D conformal, intensity-modulated or proton beam radiotherapy for localized prostate cancer. Cancer (in press).
6. Kim, S. et al. Late gastrointestinal toxicities following radiation therapy for prostate cancer. Eur. Urol. 60, 908-916 (2011).
7. Sheets, N. C. et al. Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA 307, 1611-1620 (2012).
8. Aizer, A. A. et al. The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 79, 379-384 (2011).
9. Konski, A., Speier, W., Hanlon, A., Beck, J. R. & Pollack, A. Is proton beam therapy cost effective in the treatment of adenocarcinoma of the prostate? J. Clin. Oncol. 25, 3603-3608 (2007).
10. Coen, J. J. et al. Acute and late toxicity after dose escalation to 82 GyE using conformal proton radiation for localized prostate cancer: Initial report of American College of Radiology Phase II study 03-12. Int. J. Radiat. Oncol. Biol. Phys. 81, 1005-1009 (2011).